Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE)

ClinicalTrials.gov ID: NCT04433585

Public ClinicalTrials.gov record NCT04433585. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 11:18 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of LY3471851 (NKTR-358) in Adults With Systemic Lupus Erythematosus

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The reason for this study is to see if the study drug LY3471851 (NKTR-358) is safe and effective in adults with systemic lupus erythematosus (SLE).

Study identification

NCT ID
NCT04433585
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Nektar Therapeutics
Industry
Enrollment
291 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years to 65 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 18, 2020
Primary completion
Jan 9, 2023
Completion
Feb 15, 2023
Last update posted
Apr 22, 2024

2020 – 2023

United States locations

U.S. sites
23
U.S. states
11
U.S. cities
21
Facility City State ZIP Site status
University of California - San Diego La Jolla California 92037
Desert Medical Advances Palm Desert California 92260
Stanford University Hospital Stanford California 94305
Inland Rheumatology & Osteoporosis Medical Group Upland California 91786
University of Colorado School of Medicine Aurora Colorado 80045
Clinical Research Center of CT/NY Danbury Connecticut 06810
Yale University School of Medicine New Haven Connecticut 06519
Stamford Therapeutics Consortium Stamford Connecticut 06905
University of Miami School of Medicine Miami Florida 33136
New Horizon Research Center Miami Florida 33165 3338
NECCR PrimaCare Research Fall River Massachusetts 02721
Washington University School of Medicine St Louis Missouri 63110
Northwell Health Great Neck New York 11021
NYU Langone New York New York 10016
MetroHealth Medical Center Cleveland Ohio 44109
Paramount Medical Research Middleburg Heights Ohio 44130
Oklahoma Medical Research Foundation Oklahoma City Oklahoma 73104-5046
Accurate Clinical Management Baytown Texas 77521
Metroplex Clinical Research Center Dallas Texas 75231
University of Texas Southwestern Medical Center at Dallas Dallas Texas 75390
Accurate Clinical Research Houston Texas 77089
Fort Bend Clinical Research, LLC Sugar Land Texas 77479
University of Washington Medical Center Seattle Washington 98195-6422

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 89 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04433585, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 22, 2024 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04433585 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →